if you bought at 30cents you'd be more optimistic. the tip is $2.80 IPO next year. Time will tell. 27% is right on the money for registration. It took 10yrs, not 20, to get to Merck. If keytruda is such a blockbuster why would Merck bother.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
